(Allergan plc)

	AGN latest price $228.3771 (-2.34%) ($228.2419 - $235.2008) on Fri. Oct. 10, 2014.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.33% (three month average)
RSI	54
Latest Price	$228.3771(-2.34%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.8% a day on average for past five trading days.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(56%)    XBI(47%)    SPY(44%)    VT(43%)    QQQ(42%)
Factors Impacting AGN price	AGN will decline at least -0.665% in a week (0% probabilities).   VIXM(-33%)    TLT(-18%)    SHY(-8%)    IGOV(-6%)    GLD(-5%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.665% (StdDev 1.33%)
Hourly BBV	0 ()
Intraday Trend	-2.3%

Resistance Level	$232.85
5 Day Moving Average	$234.13(-2.46%)
10 Day Moving Average	$233.48(-2.19%)
20 Day Moving Average	$232.85(-1.92%)
To recent high	-4.6%
To recent low	16.7%
Market Cap	$75.296b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed